Author details

Full Name

Craig H Mermel

Affiliation

ORCID

Career Start Year

2005

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37095223	Predicting lymph node metastasis from primary tumor histology and clinicopathologic factors in colorectal cancer using deep learning.	Commun Med (Lond)	2023
36192400	Deep learning models for histologic grading of breast cancer and association with disease prognosis.	NPJ Breast Cancer	2022
34561202	Evaluation of artificial intelligence on a reference standard based on subjective interpretation.	Lancet Digital Health, The	2021
35602213	Determining breast cancer biomarker status and associated morphological features using deep learning.	Commun Med (Lond)	2021
35602201	Predicting prostate cancer specific-mortality with artificial intelligence-based Gleason grading.	Commun Med (Lond)	2021
33875798	Interpretable survival prediction for colorectal cancer using deep learning.	NPJ Digit Med	2021
32763920	Current and future applications of artificial intelligence in pathology: a clinical perspective.	Journal of Clinical Pathology	2021
33065195	Closing the translation gap: AI applications in digital pathology.		2021
34400666	Comparative analysis of machine learning approaches to classify tumor mutation burden in lung adenocarcinoma using histopathology images.	Sci Rep	2021
32555646	Deep learning-based survival prediction for multiple cancer types using histopathology images.	PLoS ONE	2020
31935669	Artificial intelligence in digital breast pathology: Techniques and applications.	Breast	2020
32701148	Development and Validation of a Deep Learning Algorithm for Gleason Grading of Prostate Cancer From Biopsy Specimens.	JAMA Oncol	2020
33180129	Evaluation of the Use of Combined Artificial Intelligence and Pathologist Assessment to Review and Grade Prostate Biopsies.	JAMA network open	2020
31304394	Development and validation of a deep learning algorithm for improving Gleason scoring of prostate cancer.	NPJ Digit Med	2019
31646182	Reply: 'The importance of study design in the application of artificial intelligence methods in medicine'.	npj Digital Medicine	2019
31921487	Whole-Slide Image Focus Quality: Automatic Assessment and Impact on AI Cancer Detection.	J Pathol Inform	2019
31754638	Erratum: Publisher Correction: Development and validation of a deep learning algorithm for improving Gleason scoring of prostate cancer.	NPJ Digit Med	2019
31406351	An augmented reality microscope with real-time artificial intelligence integration for cancer diagnosis.	Nat Med	2019
31099672	Using Big Data and Predictive Analytics to Determine Patient Risk in Oncology.	American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting	2019
31304402	Similar image search for histopathology: SMILY.	NPJ Digit Med	2019
26456828	Identification of and Molecular Basis for SIRT6 Loss-of-Function Point Mutations in Cancer.	Cell Rep	2015
25758528	RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer.	Nat Commun	2015
25673644	Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway Alterations.	Cancer Discov	2015
24740812	Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis.	Blood	2014
25426837	Age-related clonal hematopoiesis associated with adverse outcomes.	N Engl J Med	2014
24390350	Discovery and saturation analysis of cancer genes across 21 tumour types.	Nature	2014
24672737	The 2013 symposium on pathology data integration and clinical decision support and the current state of field.	J Pathol Inform	2014
25171694	Computational pathology: an emerging definition.	Arch Pathol Lab Med	2014
23257362	Prognostically relevant gene signatures of high-grade serous ovarian carcinoma.	J Clin Invest	2013
23770567	Mutational heterogeneity in cancer and the search for new cancer-associated genes.	Nature	2013
23764425	Systematic interrogation of 3q26 identifies TLOC1 and SKIL as cancer drivers.	Cancer Discov	2013
24071852	Pan-cancer patterns of somatic copy number alteration.	Nat Genet	2013
22912358	Detection of preanalytic laboratory testing errors using a statistically guided protocol.	American Journal of Clinical Pathology	2012
22975378	Integrative analysis reveals an outcome-associated and targetable pattern of p53 and cell cycle deregulation in diffuse large B cell lymphoma.	Cancer Cell	2012
22628553	Recurrent hemizygous deletions in cancers may optimize proliferative potential.	Science	2012
21746896	Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer.	Proc Natl Acad Sci U S A	2011
21430779	The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset.	Nature	2011
21527027	GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers.	Genome Biol	2011
21683854	How surgical residents use social media.	Surgery	2011
21666749	Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer.	PLoS One	2011
20601955	Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy.	Nat Genet	2010
20473283	ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor.	Mod Pathol	2010
20164920	The landscape of somatic copy-number alteration across human cancers.	Nature	2010
19847166	Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1.	Nature	2009
19451690	Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions.	J Clin Invest	2009
19582159	microRNA expression during trophectoderm specification.	PLoS One	2009
19483683	Lin28 promotes transformation and is associated with advanced human malignancies.	Nat Genet	2009
19351834	PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR.	Cancer Res	2009
19193619	Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas.	Clin Cancer Res	2009
19755855	Amplification of chromosomal segment 4q12 in non-small cell lung cancer.	Cancer Biol Ther	2009